Occupational Pension Schemes (Collective Money Purchase Schemes) (Amendment) Regulations 2023

Baroness Sherlock Excerpts

Tuesday 13th February 2024 Grand Committee

Finally, the Minister referred to CDC schemes being integral to the UK’s private pension system but the proposition is rather stuck on the runway. I have just one observation but it is one that worries me: the department seems to be more preoccupied with individual member active engagement, although the evidence is heavily against it in terms of that producing good outcomes at scale, rather than effective collective or default solutions. I wonder whether the department’s strategic focus is necessarily delivering the collective or default solutions that we would like to see.

[Baroness Sherlock (Lab)]

I thank the Minister for introducing these regulations so clearly; I also thank all noble Lords who have spoken. I agree with my noble friend Lady Drake; she need never worry about her questions being dry. When it comes to pensions, dry is good. Dry is where the detail is and, with pensions, detail is everything. I am grateful to the officials for providing some excellent briefing and for answering questions from us. It may not reduce the number of our questions but I hope that it makes them better questions, so that we are at least debating the right things here in Grand Committee.

As we have heard, the purpose of this instrument is to make technical amendments to the 2022 regulations and do, in essence, two things: clarify the provisions governing how reductions to member benefits in CDC schemes can be managed; and specify the categories of flex-access draw-down to which accrued rights can be transferred when the scheme has been wound up.

I will make one quick point before I get stuck into the dry detail. This instrument amends the 2022 regulations, which allow CDC schemes for single and connected employers to apply for authorisation from the regulator. It does not change the intention of those regulations, as the Minister has explained, and it is obviously not adapting to experience because no CDC schemes are in operation. For the record, can the Minister tell the Committee why the Government concluded that the amendments were needed? Were these issues that could have been picked up in the original drafting?

I am needling not just for the sake of it but because I have covered the DWP brief for quite a long time. In the past couple of years, we have debated quite a few instruments in this Room that have been necessary either to correct drafting problems in previous sets of legislation or to clarify things that were deemed not clear enough in previous drafts. Is there any broader systemic issue here that the Minister wants to pick up on? Does he want to give us some assurance on that front?

Turning to the dry detail, I want to look first at the change to the means of smoothing reductions to benefits in CDC schemes in order to reduce the immediate impact on members. The efficacy of that smoothing mechanism is really important—particularly given that, as my noble friend Lady Drake pointed out, the Government set their face against having a buffer fund in CDC schemes. We raised this during the passage of the original Bill but the Government were reluctant to engage with Members at that point either on the full implications of not having a buffer in a CDC scheme or on the detail of how proposed annual adjustments and smoothing would work.

The 2022 regulations require existing benefits in a CDC scheme to be adjusted annually—including being cut if necessary, as we have heard—to make sure that we keep the value of assets held and the projected costs of benefits in balance. Clearly, the intention was that, where a market recovered during a period of benefit reduction, increases in benefits resulting from a late evaluation could help offset those cuts. As my noble friend Lady Drake explained very clearly, any quick bounceback of asset values could help avoid unnecessary cuts, provided that assets and costs are always held in balance. However, the 2022 regulations seemingly do not allow that, hence the need for today’s instrument.

The consequential changes to Regulation 19 also address the information that actuarial valuations must contain and must be shared with the regulator, including details of any variation to a multiannual reduction as a result of the offsetting; the effect that the offsetting has on the remaining years of the multiannual reduction; and, where the offsetting has eliminated the planned reductions, when the reductions ceased to have effect and whether any remaining increase has been applied. Are the trustees of a CDC scheme required to get the approval of the regulator before implementing any offset? Are there any penalties for failing to provide all that information to the regulator? When applying the offset after a bounceback, can there be any retrospective calculation of when the reductions in benefits ceased to take effect—that is, pensioners getting retrospective increased payments?

I turn to Regulation 5, which amends Schedule 6 to the 2022 regulations; that is intended to protect members of a CDC scheme when it decides to wind up by ensuring that the process is agreed and monitored by the regulator. Among other things, the regulations make it clear that, during the winding up of a CDC scheme, the accrued rights of nominees, dependants and survivors of members or dependents can be transferred to authorised flexi-access draw-down arrangements, as we have heard. My noble friend Lady Drake asked an important question about the position of successors in that situation, especially in the period between notification and winding up. I will ask a more basic question: can the Minister clarify comprehensively who qualifies as a successor who has accrued rights to benefits that can be transferred to a flexi-access draw-down? If I was listening correctly, he gave some examples of who might fall into that category, but were they comprehensive?

The Minister may reply by saying that the regulations make this clear. In a way, they do. Regulation 5 amends Schedule 6 to the 2022 regulations in order to introduce a series of definitions. For example, Regulation 5(1) says:

“Schedule 6 (continuity option 1: transfer out and winding up) is amended as follows”.


Regulation 5(2) says:

“In paragraph 1(1) … (c) after the definition of ‘quantification’ insert … ‘successor’ has the meaning given in paragraph 27F of Schedule 28 to the Finance Act 2004 … ‘successors’ income withdrawal’ has the meaning given in paragraph 27J of Schedule 28 to the Finance Act 2004 … ‘successor’s flexi-access drawdown fund’ has the meaning given in paragraph 27K of Schedule 28 to the Finance Act 2004”.


My heart leapt when I saw a little hyperlink next to each of these insertions, which I clicked on. Alas, they took me a footnote telling me, for example:

“Paragraph 27K was inserted by the Taxation of Pensions Act 2014, section 3, Schedule 2, Part 1, paragraph 3(1), and amended by the Finance Act 2015, section 34, Schedule 4, Part 1, paragraphs 13(6)(a) and (b)”.


I understand that there may be a good policy reason to point to a definition in tax law, rather than make your own up here; otherwise, every time that changes, so does yours. However, as I have said before, when the DWP is bringing forward secondary legislation that is this layered, it would be nice to have a Keeling schedule. In the end, I dug down and found it, but it is quite a long way down. The Finance Act 2004 is many hundreds of pages long and it took me a while to get down to the right place. It would be helpful if the Minister could do that in future. I am also conscious that, given that we have had problems with drafting legislation, if this House is going to do a good scrutiny job, it would be nice to make it as easy as possible.